Article Text


Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Tuberculosis reporting trends with infliximab and etanercept (Keystone EC, Bingham CO, Belozeroff V, Hadjiaghai L, Veith J, Shibata A, Wallis W, Zhao S. Ann Rheum Dis 2004;63(suppl I):S414–15.)

A correction to the above abstract can be found on the Annals website at

Supplementary materials

  • Corrected Abstract

    The corrected abstract is provided below.

    The abstract is available as a downloadable PDF (printer friendly file).

    If you do not have Adobe Reader installed on your computer,
    you can download this free-of-charge, please Click here


    Files in this Data Supplement: